Sponsor

Argos Therapeutics

Clinical research sponsor

Published trials5

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

5 shown

Safety and Efficacy Study of AGS-004 During Analytical Treatment InterruptionNCT01069809 · lead sponsor · 2010-07-01

COMPLETED

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIVNCT00672191 · lead sponsor · 2008-02-01

COMPLETED

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)NCT02026960 · collaborator · 2014-03-01

TERMINATED

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004NCT02042248 · collaborator · 2014-03-01

COMPLETED

A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.NCT00381212 · collaborator · 2006-09-01

COMPLETED

Sponsor roles

collaborator3

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.